Tricia Abe

Integrating research and development into the Canadian blood system

Thursday, December 14, 2023
Every year Canadian Blood Services publishes a report highlighting its achievements in research and development. The Innovation & Portfolio Management Annual Impact Report, 2022 – 2023, is now available on

Research and education highlights: Innovation and Portfolio Management in 2021–22

Thursday, November 17, 2022
Canadian Blood Services’ Innovation and Portfolio Management annual progress report for 2021–22 is now available. The report recaps the collaborations in research and education that take place every day to support our shared purpose: to help every patient, match every need and serve every Canadian.

Clinical Guide to Transfusion co-editor passes the reigns after 20 years

Thursday, September 22, 2022
Canadian Blood Services’ Clinical Guide to Transfusion co-editor Dr. Gwen Clarke is stepping back from her role after 20 years with the publication. Since 2002, Clarke has helped shape the Guide into one of the most visited resources on our professional education website.

Understanding a rare clotting disorder associated with some COVID-19 vaccines

Thursday, December 09, 2021
Discoveries made by a research team from McMaster University are providing vital information about a rare clotting reaction associated with COVID-19 vaccines that use adenovirus vectors.

Our professional education website has a new look!

Tuesday, November 30, 2021
We’re excited to launch a brand-new look for our professional education website, Canadian Blood Services’ resource hub for health-care professionals.

Dr. Alvin Zipursky devoted his career to eradicating Rh disease and inspired others to continue his work

Tuesday, November 09, 2021
In August this year Dr. Alvin Zipursky, a Canadian physician and researcher, died at the age of 90. He was renowned for improving children’s health in Canada and around the world and made research discoveries that were central to developing a life-saving treatment for a deadly disease called rhesus hemolytic disease, also known as Rh disease. Canadian Blood Services employees with a special connection to Dr. Zipursky describe how his drive to eradicate Rh disease worldwide continues to inspire their work today.

Updated resource for health-care professionals: massive hemorrhage and emergency transfusion

Tuesday, October 05, 2021
The latest evidence on managing patients with massive hemorrhage, a major cause of potentially preventable deaths, is now available in a recently updated chapter of Canadian Blood Services’ Clinical Guide to Transfusion.

International collaboration on the cusp of delivering a new, more precise way to type blood

Wednesday, September 29, 2021
A powerful collaboration between blood services, research institutions and industry leaders promises to advance blood transfusion therapy to new levels of precision and safety.

2020 Surveillance Report shows blood supply remained above target in first year of pandemic

Thursday, September 16, 2021
Canadian Blood Services recently published its annual Surveillance Report, a summary of monitoring efforts related to transmissible infection testing in donors; possible transfusion-transmitted infections in recipients; and new, emerging pathogens. Surveillance also includes monitoring of donor safety.

Improving red blood cell inventory to support patients with sickle cell disease

Tuesday, September 07, 2021
Transfusions can be a life-saving treatment for people living with sickle cell disease but finding compatible blood can be a challenge because Black and racialized donors—the ones with the best potential to match most SCD patients— are underrepresented in the donor pool. Read about initiatives that can support this patient group by improving the red blood cell inventory.